A 7-month-old New Forest foal presented for episodes of recumbency and stiffness with myotonic discharges on electromyography. The observed phenotype resembled congenital myotonia caused by CLCN1 mutations in goats and humans. Mutation of the CLCN1 gene was considered as possible cause and mutation analysis was performed. The affected foal was homozygous for a missense mutation (c.1775A>C, p.D592A) located in a well conserved domain of the CLCN1 gene. The mutation showed a recessive mode of inheritance within the reported pony family. Therefore, this CLCN1 polymorphism is considered to be a possible cause of congenital myotonia. Ó 2011 Elsevier B.V.
Introduction
Myotonias are acquired or inherited neuromuscular disorders characterized by the slow relaxation of muscles after voluntary contraction or electrical stimulation. Genetic forms of congenital myotonia are characterized by impaired function of chloride, sodium or potassium ion transport channels in the skeletal muscle membrane [1] [2] [3] . It has been previously shown that sarcolemmal chloride conduction is required to preserve membrane potential and functional chloride channels are essential for resting potential stabilization. Different mutations in genes that code for ion channels are involved in several hereditary muscular diseases [1, 2, 4, 5] . Human congenital myotonia is caused by recessive or dominant mutations of CLCN1 causing Becker's (OMIM 255700) or Thomsen's disease (OMIM 160800). The muscle chloride channel CLCN1 regulates the electrical excitability of the skeletal muscle membrane [1, 2, 6, 7] .
The association between myotonia and chloride conduction was first described in myotonic mice [8] and the first mutation in the CLCN1 gene shown to cause myotonia was found in domestic animals. The "fainting" goats which developed severe acute muscle stiffness and became immobile during vigorous movements or when startled showed a missense mutation of the CLCN1 gene (p.A885P) [4] . In 1962 the first case of suspected equine myotonia was reported [7] . As the phenotype of the New Forest pony reported here strongly resembled the clinical signs and 0960-8966 Ó 2011 Elsevier B.V. doi:10.1016/j.nmd.2011. 10 .001 biochemical findings of both human and goat myotonia, we hypothesized that mutations in the CLCN1 gene might also be responsible for the clinical signs observed in this animal.
In this case study we report a missense mutation in the equine CLCN1 gene associated with a recessive inherited myotonia disease phenotype.
Case report
A 7-month-old New Forest pony stallion was presented to the Equine Clinic of Utrecht University. During the first 4-6 weeks of life the foal had developed normally. Main abnormalities observed by the owner were recurrent episodes of recumbency and difficulty rising to its feet as a result of muscle stiffness. The frequency of these episodes of recumbency had increased in the months prior to presentation. At the time of clinical examination the foal was found to be well developed with above average muscle mass when compared to other foals of the same breed. When stimulated (for example by opening of the stable door or when getting up) the foal seemed hyperreactive and temporary protrusion of the third eyelid occurred due to retraction of the eye uni-or bilaterally (Fig. 1A) . During vocalization the whinnying ended in a high pitched squeaking, or a deep growling noise. The pelvic limbs were extremely straight (minimal flexion of the tarsi) (Fig. 1B) , and the foal walked reluctantly with a stiff gait. When walking, the pelvic limbs did not always follow the track of the thoracic limbs and the foal easily lost its balance as a result of stiffness and occasionally lost its footing. General examination revealed no other abnormalities than retraction of the eye and protrusion of the third eyelid for approximately 30 s following inspection of the conjunctiva. Neurological examination revealed normal mentation, no cranial nerve deficits and occasionally a wide-based stance. Postural reactions were impossible to perform and picking up the limbs was hampered by the muscle rigidity.
Manual flexion of the proximal metacarpo/metatarso-phalangeal joints was impossible. Passive movements of the neck and trunk were very limited and the foal was easily pulled off balance. Although the foal showed signs of weakness, ataxia was absent and the rigidity seemed to be the major problem.
Blood biochemical analysis showed a plasma sodium The fractional excretion of all electrolytes in urine was within normal limits and the acid-base balance of the blood was normal. Muscle enzyme activities were not measured. DNA testing for the mutation of the skeletal muscle sodium channel gene (SCN4A) causing hyperkalemic periodic paralysis in Quarter horses was negative. Electromyographic (EMG) needle examination [9, 10] using Viking Quest commercial EMG equipment showed prolonged insertional activity caused by spontaneous waxing and waning discharges after needle insertion and as a result of muscle contraction in all measured muscles including the subclavian and descending pectoral muscle. The results of EMG examination were consistent with myotonia [2, 5, 11, 12] (Fig. 2) .
Routine morphological (Gomori trichrome, H&E) and histochemical analysis (succinic dehydrogenase, cytochrome oxidase and m-ATPase) of biopsy samples from the M. semimembranosus, M. gluteus medius, M. vastus lateralis and M. triceps brachii caput longum were performed. There was no evidence of muscle damage, rhabdomyolysis or central nuclei but extreme heterogeneity in fiber diameters was noticed in all four muscle specimens examined. In the caput longum of the M. triceps brachii two distinct type 1 fiber populations were observed. The first consisted of fibers with a diameter of 50.36 ± 9.3 lm, whilst the second population (Fig. 3 ) consisted of fibers with a very small diameter, 20.21 + 8.8 lm.
We hypothesized that a mutation in the CLCN1 gene may have been responsible for the clinical signs observed in the present case [7] . The analysed pedigree data suggested a monogenic autosomal recessive inheritance (Fig. 4A) . Parents of the affected foal did not show any clinical signs. EDTA blood samples of the affected foal, its dam, its sire, other related (n = 22) and unrelated (n = 21) New Forest ponies, and 56 horses of various breeds were examined (Supplementary Table 2 ). Genomic DNA was isolated using standard methods. PCR primer pairs were designed for the amplification of CLCN1 exons with flanking introns (Table 1 ) as described previously [13] . The equine CLCN1 gene has 23 exons (NCBI Gene ID: 100050692), the total predicted transcript length is 2970 bp (Genbank acc. XM_001915636) encoding a protein of 989 aa (Genbank acc. XP_001915671). Initially, all exons and several introns of the equine CLCN1 gene were amplified using standard protocols applied to a total of four DNA samples from the affected foal, its dam, its sire (Fig. 4A ) and one unrelated control horse. The purified PCR products were directly sequenced from both directions using the ABI BigDye v3.1 kit and an ABI 3730 capillary sequencer (LifeTechnologies, Rotkreuz, Switzerland). Sequence data were analysed using Sequencher 4.9 (GeneCodes, Ann Arbor, MI, USA).
A total of three polymorphisms were identified, two single nucleotide substitutions in CLCN1 exon 15 (c.1593A>G and c.1775A>C) and a three base pair insertion (c.2652_2653insCTT) in exon 23. No other mutations in exonic or splice site regions of the CLCN1 gene were identified. The c.1593A>G transition did not result in amino acid exchange. The three family members (the foal and its parents) were homozygous for the mutant allele 1593G and the unrelated control horse was homozygous for the wildtype allele 1593A. This mutation was therefore not associated with the disease. A similar genotype distribution was observed for the in-frame insertion (c.2652_2653insCTT) leading to an additional leucine residue after codon 884 which affects a less conserved protein region. In conclusion, these two sequence variants are highly unlikely to be related to the proper function of the encoded protein.
Interestingly, the c.1775A>C transversion led to an amino acid replacement where aspartic acid is replaced by alanine (p.D592A). The affected pony was homozygous C/C for mutant allele1775C, the dam and the sire were heterozygous A/C and the control horse was homozygous A/ A for the wildtype allele 1775A (Fig. 4B) .
To verify the association of the c.1775A>C mutation with the clinical disease presentation an additional 42 New Forest ponies and 56 horses of 13 different breeds were screened using the methods described above (Supplementary Table 2 ). None of the investigated animals was homozygous for the mutant allele 1775C. Of the genotyped New Forest ponies eight mares (including the mother) and one stallion (the sire of the affected foal) were heterozygous (A/C) for the mutant 1775C allele while all other horses and ponies were homozygous A/A (Supplementary Table 2 , Fig. 4A ).
To test whether the observed missense mutation affects CLCN1 splicing we amplified the entire CLCN1 cDNA of the affected foal. Total RNA extracted from four different skeletal muscles of the affected pony was subjected to a reverse transcription-PCR (RT-PCR) to analyse the CLCN1 transcript. The entire coding sequence of 2970 bp of the CLCN1 gene was amplified using five overlapping PCR products (Table 1 ) and subsequently re-sequenced from both directions as described above. No alterations of the transcript could be observed apart from the polymorphisms detected at the genomic level.
Discussion
Myotonia is a primary skeletal muscle disease characterized by delayed relaxation of skeletal muscle after sudden forceful contraction, sometimes associated with clinical signs of weakness. In humans, congenital myotonia, type Thomsen [14] and generalized myotonia, type Becker [15] are inherited as an autosomal dominant and recessive trait, respectively [3] . Mutations of the CLCN1 gene have been identified in adr/adr mice [8] and "fainting" goats [4] . Further, CLCN1 animal models have been described in dogs. Independent autosomal CLCN1 mutations, with a recessive mode of transmission, cause myotonic phenotypes in Table 1 PCR primer pairs designed for the amplification of CLCN1 exons with flanking introns.
Primer name
Forward primer sequence Reverse primer sequence bp°C PCR  CLCN1exon1  GGCTGTTCCTCAGGTTCTCA  TCTCCAAGTGCACACTCAGC  604  60  CLCN1exon2  AGAACTTGGCGTCCTTGATG  TAGGTGTGCATGTGGAGAGG  482  60  CLCN1exon3  CATCTTCTCACGTTGCCTTG  CCTGGACCAGATTCACACCT  509  60  CLCN1exon4 + 5  GTGGCATCTTGTGAGGTGAA  GGTCCACGTCTGCTCCTAGA  717  60  CLCN1exon6  AATGTTCCTCCATCGAATGC  AGCACAAGAAGGCAATGTGG  463  60  CLCN1exon7  TGGCTTACCTGCCTTCCATA  GAACAAGATCAGGCAAGTGGA  389  60  CLCN1exon8  GCCTGATCCTGACGTTCTGT  CGTCTGCTCCACGACCTTAT  531  60  CLCN1exon9 + 10  GGTTGGAGCAAGGAAGGAAT  CAGAGCATTCTGTCCACCAA  706  60  CLCN1exon11 + 12  TTGCAGGAGTTCAGTGTGGT  AGGCTGTGGTCTCCAAGCTA  694 CLCN1_cds_1  GAGCTGTATTGTGGGGAGGA  AGGCCTTGAGGGTGAGGTAT  693  60  CLCN1_cds_2  CTGGGTCACCTTCCCACTTA  GGATACAGCAGGAGGTGCTT  693  60  CLCN1_cds_3  AATGGATTTCCCCTTTGACC  AAATTTGCTGAGCTGGTTCC  790  60  CLCN1_cds_4  CAGCCCTCCCTCTATGACAG  CGTTGAATCCTGGGTTGTTT  657  60  CLCN1_cds_5  CCAAGACCCTCCATCTTTCA  GGCCTCTTGACAGTCTGCAT  717  60 bp = product length;°C = annealing temperature. Miniature Schnauzers [16] and in Australian Cattle Dogs [11] . The pony presented in this report demonstrated clinical signs and EMG changes strikingly similar to those observed in myotonic goats, supporting our assumption that the disease phenotype in these two domestic species might have been caused by independent CLCN1 gene mutations [5, 12] . Blood from the foal was examined for the presence of mutations in the CLCN1 gene and found to be homozygous for the missense mutation c.1755A>C in exon 15. The associated CLCN1 mutation was probably introduced by the grandfather of the affected foal, as all carriers identified so far could be traced back to this stallion (Fig. 4A ). This putative founder was the paternal grandfather and the maternal grand-grandfather of the affected foal. Sequencing of unrelated controls of different breeds (Supplementary Table 2 ) showed that the CLCN1 c.1775A>C polymorphism was not present in other horses. The fact that none of the examined horses unrelated to the New Forest pony breed was shown to be carrier of the disease associated allele, indicates that this might be a quite recent mutation, limited to a single breeding line which
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has not yet spread into the general population. It is possible that a spontaneous CLCN1 germline mutation occurred in the assumed founder stallion. The consequence of the c.1775A>C mutation was the substitution of aspartic acid for alanine in codon 592 of the C-terminal cytoplasmic domain of the equine CLCN1 protein. There was no indication that this mutation affects splicing of CLCN1. The affected amino acid position is highly conserved across mammalian orthologues (Fig. 5) . The human CLCN1 protein is enclosed by two related protein domains, the voltage gated chloride channel and the CBS domain, respectively [17] . As CLCN1 functions as a homooligomer, probably consisting of four subunits [17] , it is possible that the codon 592 mutation affects the proper formation of the functional ion channel. The potential impact of this myotonia associated amino acid substitution was evaluated by PolyPhen (http://genetics.bwh.harvard.edu/pph/). The substitution affected a strongly conserved residue and was predicted to be "probably damaging" with a PSIC score difference of 2.25, which implies that the substitution is very likely to affect protein function or structure. The deficiency of functional chloride channels is a very plausible explanation for the observed phenotype. The equine missense mutation seems to be perfectly associated with the condition even though it is located distant to the causative CLCN1 mutation described in "fainting" goats [4, 6, 18] .
The morphometric results resemble data reported for human patients affected by congenital myotonia: a selective atrophy of type I fibers has been observed in human skeletal muscles [19] together with muscle fiber hypertrophy [1] . However, breed and age differences do exist in muscle morphology [20] and muscle tissue of other New forest ponies was not available to strengthen these conclusions. Human congenital myotonia has also been reported to be result of a heterogeneous trait: apart from the association of congenital myotonia with type I fiber atrophy, generalized muscle fiber hypertrophy was observed in three quarters of patients affected by recessive myotonia, whereas the remainder had normal muscle fiber size [1, 21] . A moderate hypertrophy of myotonic fibers has previously been reported in both myotonic goats, [22] and more recently in myotonic dogs [23] . Muscle enzyme activities were not available from this patient but are reported to vary from normal to moderately elevated [2, 11] and therefore do not provide conclusive evidence.
In conclusion, this study reports the first case of congenital myotonia in horses for which the molecular genetic cause was analyzed and which was associated with a missense mutation of the equine CLCN1 gene. It illustrates the importance of precise clinical recognition of putative inherited diseases and illustrates once again the value of the recently deciphered horse genome sequence in unraveling the molecular basis of such genetic anomalies. Our finding enables direct genetic testing and the eradication of this genetic disease from the New Forest pony breeding population. Furthermore, this study provides an additional genetically characterized large animal model for human myotonia.
